(Q27863422)

2

0 references

M S Minkes

3

0 references

J A Ferrendelli

4

0 references

H Sprecher

Proceedings of the National Academy of Sciences of the United States of America

5

0 references

language of work or name

English

0 references

publication date

February 1979

0 references

published in

1 reference

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

volume

76

0 references

page(s)

944-8

0 references

issue

2

0 references

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=383100

Role of cyclic AMP in platelet function.

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=383100

Unstable metabolites of arachidonic acid and their role in haemostasis and thrombosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=383100

Cardiac and renal prostaglandin I2. Biosynthesis and biological effects in isolated perfused rabbit tissues

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=383100

A novel prostaglandin is the major product of arachidonic acid metabolism in rabbit heart

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=383100

Cyclic adenosine 3′,5′-monophosphate and prostacyclin inhibit membrane phospholipase activity in platelets

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=383100

Application of imidazole as a selective inhibitor thromboxane synthetase in human platelets

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=383100

Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=383100

Modulation of platelet cyclic nucleotide content by PGE1 and the prostaglandin endoperoxide PGG2

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=383100

Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=383100

Substances that increase the cyclic AMP content prevent platelet aggregation and the concurrent release of pharmacologically active substances evoked by arachidonic acid

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=383100

The chemical structure of prostaglandin X (prostacyclin)

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=383100

Interactions of the pharmacological receptors of blood platelets with adenylate cyclase.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=383100

Radioimmunoassay for cyclic nucleotides. I. Preparation of antibodies and iodinated cyclic nucleotides

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=383100

Hormone selective lipase activation in the isolated rabbit heart

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=383100

Coronary tone modulation: formation and actions of prostaglandins, endoperoxides, and thromboxanes

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=383100

Prostacyclin (PGX) is the endogenous metabolite responsible for relaxation of coronary arteries induced by arachindonic acid

2 June 2018

1 reference

12 December 2020

Characterization of a novel metabolic pathway of arachidonate in coronary arteries which generates a potent endogenous coronary vasodilator

1 reference

12 December 2020

Prostaglandins: Their Disappearance from and Release into the Circulation

1 reference

12 December 2020

Preparation and purification of lipid hydroperoxides from arachidonic and gamma-linolenic acids

1 reference

12 December 2020

Thromboxanes: selective biosynthesis and distinct biological properties

1 reference

12 December 2020

Paradoxical endogenous synthesis of a coronary dilating substance from arachidonate

1 reference

12 December 2020

The synthesis of 1‐14C‐arachidonate and 3‐14C‐docosa‐7,10,13,16‐tetraenoate

1 reference

12 December 2020

A lipid peroxide inhibits the enzyme in blood vessel microsomes that generates from prostaglandin endoperoxides the substance (prostaglandin X) which prevents platelet aggregation

1 reference

12 December 2020

Endoperoxides and thromboxanes structural determinants for platelet aggregation and vasoconstriction

1 reference

12 December 2020

Effect of acetylsalicylic acid, other nonsteroidal anti-inflammatory agents, and dipyridamole on human blood platelets

1 reference

12 December 2020